4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzohydrazide

Catalog No. :
ACOTFB956
CAS No. :
276694-16-7
Molecular Formula :
C13H19BN2O3
Molecular Weight :
262.12

IUPAC Name:4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzohydrazide

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$144.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzohydrazide
IUPAC Name4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzohydrazide
MDL No.MFCD07783860
Molecular FormulaC13H19BN2O3
Molecular Weight262.12
SMILESO=C(NN)C1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1
InChI KeyGFZSUVMUIACQHK-UHFFFAOYSA-N
Synonym4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzohydrazide | AT16842 | BS-22182 | MFCD07783860 | DTXSID80611673 | A26768 | CS-0174627 | J-016849
CAS No.276694-16-7
PubChem CID21253979

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P310+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOTFB956 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGASM631 route compound structure diagram
    ACGASM631171364-80-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOTFB956 route product structure diagram
    ACOTFB956276694-16-7 In Stock
Inquiry

2. ACOTFB956 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXIR245 route compound structure diagram
    ACFXIR245180516-87-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOTFB956 route product structure diagram
    ACOTFB956276694-16-7 In Stock
Inquiry

Comments (0)